LIPOTEK PTY LTD has a total of 20 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, China and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are LEVERTON LICENCE HOLDINGS LTD, SUSAVION BIOSCIENCES INC and ARTIFICIAL CELL TECHNOLOGIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | China | 4 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Jackson David C | 9 |
#2 | Parish Christopher Richard | 8 |
#3 | Parish Christopher | 6 |
#4 | Altin Joseph | 5 |
#5 | Price Jason David | 5 |
#6 | Atmosukarto Ines | 5 |
#7 | Parish Christopher R | 4 |
#8 | Richard Parish Christopher | 2 |
#9 | Joseph Altin | 1 |
Publication | Filing date | Title |
---|---|---|
CN107207614A | Chimeric protein | |
CN101151020A | Adjuvanting material | |
AU2006209809A1 | Adjuvanting material | |
CN1893925A | In vivo targeting of dendritic cells |